Extracorporeal Membrane Oxygenation Machine Market : Latest Trends and Forecast Analysis upto 2024

Extracorporeal membrane oxygenation (ECMO), also referred as extracorporeal life support (ECLS), is an extracorporeal (occurring outside the body) method of providing both respiratory and cardiac support to the persons whose lungs and heart are unable to perform optimum gas exchange to sustain life. This system offers heart-lung bypass support outside the person’s body. The ECMO system is finding more applications in adults with respiratory and cardiac failure, than children, as it has been mostly used earlier. The ECMO machine is similar to a heart-lung bypass machine used in open-heart surgery. The ECMO machine is exclusively a life-sustaining intervention, and usually used in the later treatment of a person having lung or heart failure. The machine functions by taking out blood from the person’s body and artificially oxygenates the red blood cells and eliminates the carbon di oxide.

The growth of ECMO machine market is attributed to rising respiratory diseases, cardiovascular diseases coupled with surging frequency of Chronic Obstructive Pulmonary Disease (COPD). The adoption of unhealthy lifestyle and the associated ill effects resulting in lifestyle disorders are likely to further amplify the COPD incidence rate. The most recognized risk factors, such as increasing smoking trend and tobacco consumption in both males and females are the high impact factors fueling the growth of market significantly. Additionally, the growing geriatric population and rising number of people suffering with diseases in populous countries are expected to drive the market growth. ECMO machines are used for patients suffering with respiratory complications, it is regularly used for pediatric, neonate, and adult patients due to the subtle nature of this target population, the demand for these machines and their adoption rate is set to escalate.

Browse full report on Extracorporeal Membrane Oxygenation Machine Market - http://www.transparencymarketresearch.com/extracorporeal-membrane-oxygenation-machine-market.html

Increasing uptake of these machines because of the related benefits has initiated the technological advancements utilized in the ECMO machines. The growing number of ECMO centers, growing adoption of ECMO as a link to lung transplantation, along with technological refinements underway, offers lucrative growth opportunities to the market. However, technical failures associated with extracorporeal membrane oxygenation machine along with the complications such as infections, bleeding, etc. may hamper the growth of market. Furthermore, lack of skilled professionals and high cost are other factors restraining growth of the market.

The global extracorporeal membrane oxygenation machine market can be segmented on the basis of modality in to arterio-venous (AV), veno-venous (VV), and veno-arterial (VA), depending on the different ways of ECMO circuit set up. They are engaged to enable the process of gas exchange and offer hemodynamic support to the patients suffering with cardiac or respiratory failure. The considerable market share of veno-venous (VV) segment can be attributed to the increasing lung transplants, rising incidence of respiratory failure coupled with technological advancements. The market can be further segmented on the basis of applications in to Cardiac, Respiratory, and Extracorporeal Cardiopulmonary Resuscitation (ECPR). These segments can be further categorized as adult, pediatric, and neonate application areas. The respiratory-based segment is the major shareholding segment attributed to rising prevalence of COPD, growing number of patients suffering from respiratory disorders such as chronic bronchitis and emphysema. The extensive upsurge in health awareness are expected to propel the market growth significantly. Geographically, the extracorporeal membrane oxygenation machine market can be segmented in to five regions, North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. North America region is dominating the market due to availability of advanced and well developed facilities in hospitals, government funding, well-built reimbursement network, and encouraged adoption of ECMO machines. Asia Pacific region is projected to witness rapid growth in the market due to increase in number of patients suffering with cardiopulmonary conditions, like asthma, emphysema chronic bronchitis, and respiratory failure.

Key players of the global extracorporeal membrane oxygenation machine market are LivaNova PLC, Medtronic plc, EUROSETS S.r.l, ALung Technologies, Inc., OriGen Biomedical, Inc., NIPRO Corporation, MicroPort Scientific Corporation, Getinge Group, Terumo Corporation, XENIOS AG, and others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22187

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.